The journal reviews how to care for children with neuroblastoma receiving 131I-metaiodobenzylguanidine therapy.

Please click on the Take Course button to read the article and take the quiz. After successful completion, you will receive your contact hours. 

This course is open from 8/1/2023-8/31/2023 and is not accessible after that.

Overall Objectives:

At the end of this session, learners should be able to:

  1. Demonstrate knowledge of nurses’ experiences caring for children with neuroblastoma receiving 131I-metaiodobenzylguanidine therapy by passing a post-test with 80% or better accuracy.

Resource Individual: Kristine Hoelle, MSN, RN, CPHON, CPN; Advocate Aurora Health

Email and Phone: Kristine.Hoelle@aah.org or 41-4227

Content Expert: Nicole Torgerson, BSN, RN, CPN; Advocate Aurora Health

Email: Nicole.torgerson@aah.org

Session date: 
08/01/2023 - 12:00am CDT to 08/31/2023 - 11:45pm CDT
Add to calendar: 
  • 1.10 Attendance
    Attendance Credit
  • 1.10 Continuing Nursing Education (CE)
    Aurora Health Care is an approved provider of continuing nursing education by the Wisconsin Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.10 contact hours have been awarded to this activity by the Wisconsin Nursing Association. To receive contact hours, participants must attend the entire activity.

Please login or register to take this course.